Results 1 to 10 of about 103,495 (263)

Handling persistent cardiac troponin elevation in asymptomatic athletes: The role of macrocomplexes [PDF]

American Heart Journal Plus
Study objective: Return-to-play (RTP) decision includes cardiac troponin I returning to baseline. Formation of antibodies to cardiac troponin I (macrocomplexes) may lead to persistent, false positively elevated cardiac troponin I and may induce ...
Simon Wernhart, Martin Halle, Sebastian Zenk   +2 more
doaj   +2 more sources

Clinical Utility of Cardiac Troponin I and Cardiac Troponin T Measurements [PDF]

Acta Medica, 1997
The measurement of CK-MB remains the test of choice for confirmation or exclusion of AMI and probably will remain the test of choice for routine diagnosis in the near future.
Michaela Adamcová, Zdeněk Kokštein, Jaroslava Vávrová   +2 more
doaj   +3 more sources

Cardiac Troponin: Fragments of the Future? [PDF]

JACC Adv
McGrath S, Alaour B, Kampourakis T, Marber M.   +3 more
europepmc   +2 more sources

Cardiac biomarkers and COVID-19: A systematic review and meta-analysis

Journal of Infection and Public Health, 2021
Objective: To systematically investigate the relationship between cardiac biomarkers and COVID-19 severity and mortality. Methods: We performed a literature search using PubMed, Web of Science, and Google Scholar.
Wen An, Ju-Seop Kang, Qiuyang Wang, Tae-Eun Kim   +3 more
doaj   +1 more source

Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panel

Open Heart, 2021
Cardiac disease is now the leading cause of death in Duchenne muscular dystrophy (DMD). Clinical evaluations over time have demonstrated asymptomatic cardiac troponin elevations and acute elevations are associated with symptoms and cardiac dysfunction in
Christopher F Spurney, Lawrence Charnas, Linda Cripe, Kan Hor, Nicholas King, Kathi Kinnett, Elizabeth M McNally, John-Michael Sauer, Lee Sweeney, Chet Villa, Larry W Markham   +10 more
doaj   +1 more source

Inverted Takotsubo Syndrome With HELLP Syndrome: A Case Report

Frontiers in Cardiovascular Medicine, 2022
BackgroundTakotsubo syndrome is an acute cardiac condition involving sudden, transient apical ballooning of the left ventricle of the heart that may be triggered by emotional stress and some non-cardiac conditions.
Paul Gabarre, Pablo Ruiz, Camille Chenevier-Gobeaux, Etienne Charpentier, Laurie Soulat-Dufour, Laurie Soulat-Dufour, Ariel Cohen, Ariel Cohen, Laurence Monnier-Cholley, Lotfi Chemali, Hélène François, Hélène François, Mathieu Kerneis, Guillaume Lefèvre, Mathieu Boissan, Mathieu Boissan   +15 more
doaj   +1 more source

Cardiac troponin as a prognosticator of mortality in patients with sepsis: A systematic review and meta‐analysis

Immunity, Inflammation and Disease, 2023
Background The impact of cardiac troponin on the short‐term and long‐term prognosis of patients with sepsis remains uncertain. Therefore, we conducted a meta‐analysis to investigate the role of cardiac troponin as a potential indicator for sepsis ...
Peiqiu Zheng, Xing Wang, Tao Guo, Wei Gao, Qiang Huang, Jie Yang, Hui Gao, Qian Liu   +7 more
doaj   +1 more source

Raised cardiac troponins [PDF]

BMJ, 2004
Causes extend beyond acute coronary syndromes Cardiac troponins are regulatory proteins of the thin actin filaments of the cardiac muscle. Troponin T and troponin I are highly sensitive and specific markers of myocardial injury. Serial measurement of troponin I or troponin T has become an important tool for risk stratification of patients presenting ...
Peter, Ammann, Matthias, Pfisterer, Thomas, Fehr, Hans, Rickli   +3 more
openaire   +2 more sources

The impact of cardiac troponin in elderly patients in the absence of acute coronary syndrome: A systematic review

International Journal of Cardiology: Heart & Vasculature, 2020
Comorbidities are common risk factors for rising cardiac troponin in non-acute coronary syndromes conditions. Furthermore, the risk for all-cause mortality appears to be correlated to the troponin levels.
Seyed Mahdi Sedighi, Michel Nguyen, Abdelouahed Khalil, Tamas Fülöp   +3 more
doaj   +1 more source

Donor Cardiac Troponin for Prognosis of Adverse Outcomes in Cardiac Transplantation Recipients: a Systematic Review and Meta-analysis

Transplantation Direct, 2022
Background. Cardiac troponin is a highly specific and widely available marker of myocardial injury, and elevations in cardiac transplant donors may influence donor selection.
Zhengyang Liu, MD(Distinct), BBiomed, Luke A. Perry, MBBS(Hons), BSc, Jahan C. Penny-Dimri, MBBS(Hons), BHlthSc(Hons), LLB(Hons), Michael Handscombe, MD, BSc, Isabella Overmars, BSc, Mark Plummer, MBBS, PhD, FCICM, Reny Segal, MBChB, FANZCA, Julian A. Smith, MBBS, MS, MSurgEd, FRACS, FCSANZ, FFSTRCSEd, FAICD   +7 more
doaj   +1 more source